Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mandal

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Peptides|February 12, 2002
Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activityM Mandal, M V Jagannadham, R Nagaraj
Viruses|May 28, 2025
Evolution of Antiviral Drug Resistance in SARS-CoV-2Roy Dinata, Piyush Baindara, Santi M Mandal
International Journal of Antimicrobial Agents|November 9, 2020
LPD-12: a promising lipopeptide to control COVID-19Trinath Chowdhury, Piyush Baindara, Santi M Mandal
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2026
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implicationsAritra Jana, Debnarayan Khatua, Santi M Mandal
Current Pharmaceutical Design|December 29, 2017
Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut HealthDebarati Paul, Sounik Manna, Santi M Mandal
Ecotoxicology and Environmental Safety|March 16, 2019
Biocides and health-care agents are more than just antibiotics: Inducing cross to co-resistance in microbesDebarati Paul, Ranadhir Chakraborty, Santi M Mandal
Journal of Infection and Public Health|July 27, 2020
Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2Sounik Manna, Piyush Baindara, Santi M Mandal
Infectious Disorders Drug Targets|July 29, 2020
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential ProteasesTrinath Chowdhury, Gourisankar Roymahapatra, Santi M Mandal
Bioengineering (Basel, Switzerland)|August 29, 2024
CycP: A Novel Self-Assembled Vesicle-Forming Cyclic Antimicrobial Peptide to Control Drug-Resistant <i>S. aureus</i>Piyush Baindara, Dinata Roy, Santi M Mandal
Indian Heart Journal|January 1, 1985
On modelling of enzyme release from infarcted myocardium and estimation of infarction sizeM Mandal, A K Mandal, D Mukherjee
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Peptides|February 12, 2002
Antibacterial activities and conformations of bovine beta-defensin BNBD-12 and analogs:structural and disulfide bridge requirements for activityM Mandal, M V Jagannadham, R Nagaraj
Viruses|May 28, 2025
Evolution of Antiviral Drug Resistance in SARS-CoV-2Roy Dinata, Piyush Baindara, Santi M Mandal
International Journal of Antimicrobial Agents|November 9, 2020
LPD-12: a promising lipopeptide to control COVID-19Trinath Chowdhury, Piyush Baindara, Santi M Mandal
Expert Review of Pharmacoeconomics & Outcomes Research|April 14, 2026
Antimicrobial resistance as an economic externality: optimal control, Pigouvian taxation, and governance implicationsAritra Jana, Debnarayan Khatua, Santi M Mandal
Current Pharmaceutical Design|December 29, 2017
Antibiotics Associated Disorders and Post-biotics Induced Rescue in Gut HealthDebarati Paul, Sounik Manna, Santi M Mandal
Ecotoxicology and Environmental Safety|March 16, 2019
Biocides and health-care agents are more than just antibiotics: Inducing cross to co-resistance in microbesDebarati Paul, Ranadhir Chakraborty, Santi M Mandal
Journal of Infection and Public Health|July 27, 2020
Molecular pathogenesis of secondary bacterial infection associated to viral infections including SARS-CoV-2Sounik Manna, Piyush Baindara, Santi M Mandal
Infectious Disorders Drug Targets|July 29, 2020
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential ProteasesTrinath Chowdhury, Gourisankar Roymahapatra, Santi M Mandal
Bioengineering (Basel, Switzerland)|August 29, 2024
CycP: A Novel Self-Assembled Vesicle-Forming Cyclic Antimicrobial Peptide to Control Drug-Resistant <i>S. aureus</i>Piyush Baindara, Dinata Roy, Santi M Mandal
Indian Heart Journal|January 1, 1985
On modelling of enzyme release from infarcted myocardium and estimation of infarction sizeM Mandal, A K Mandal, D Mukherjee
Pageof 27